Jagpal Sukhi

Chief Financial Officer at NOVELION THERAPEUTICS INC. · on record since May 15, 2013
Director at SUTRO BIOPHARMA, INC. · on record since Jun 9, 2026
Chief Financial Officer at Sierra Oncology, Inc. · on record since Jul 15, 2015

Insider trading activity of Jagpal Sukhi

Transactions on record: 41; since Aug 7, 2012

Open-market buys: 0

Open-market sells: 3; $628.2K

Companies traded: 3; last filing Jun 9, 2026

Figures computed from official regulatory filings — .

Companies where Jagpal Sukhi has traded

SUTRO BIOPHARMA, INC.5 tx · Jun 9, 2026
Sierra Oncology, Inc.22 tx · Jul 1, 2022
NOVELION THERAPEUTICS INC.14 tx · $1M · Jul 17, 2013

Track record of Jagpal Sukhi

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Jagpal Sukhi

Co-insiders of Jagpal Sukhi

NEWELL WILLIAM JNOVELION THERAPEUTICS INC. +1
Abingworth LLPSierra Oncology, Inc.
Aegerion Pharmaceuticals, Inc.NOVELION THERAPEUTICS INC.
Aggarwal GauravSierra Oncology, Inc.
ALBINI EDWARD CSUTRO BIOPHARMA, INC.
Allen Andrew RSierra Oncology, Inc.
Alta Partners Management VIII, LLCSUTRO BIOPHARMA, INC.
Alta Partners VIII, L.P.SUTRO BIOPHARMA, INC.
ANDERSEN MARCNOVELION THERAPEUTICS INC.
Anderson Keith EdwardSierra Oncology, Inc.
ANIDO VICENTE JRNOVELION THERAPEUTICS INC.
Aryeh JasonNOVELION THERAPEUTICS INC.
Ashiya MonaSierra Oncology, Inc.
Assaly Dori ChristineNOVELION THERAPEUTICS INC.
ASSOULINE, ELIAVNOVELION THERAPEUTICS INC.
AUXILIUM PHARMACEUTICALS INCNOVELION THERAPEUTICS INC.
AXIAL CAPITAL MANAGEMENT, LLCNOVELION THERAPEUTICS INC.
Axial Capital Master, L.P.NOVELION THERAPEUTICS INC.
AZAB MOHAMMADNOVELION THERAPEUTICS INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
SUTRO BIOPHARMA, INC.Listing on record	Jun 9, 2026	AwardD (derivative)	10,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Dec 29, 2025	AwardD (derivative)	1,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Jun 10, 2025	AwardD (derivative)	50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Aug 12, 2024	AwardD (derivative)	28,959	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Aug 12, 2024	AwardD (derivative)	35,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,750	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-5,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-3,859	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-94,113	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-49,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-5,887	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-4,509	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-4,200	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,218	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jun 17, 2022	AwardD (derivative)	12,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 14, 2022	AwardD (derivative)	50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jan 28, 2022	AwardD (derivative)	12,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 17, 2021	AwardD (derivative)	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Aug 12, 2020	AwardD (derivative)	5,887	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Feb 27, 2020	AwardD (derivative)	94,113	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 5, 2019	AwardD (derivative)	200,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 7, 2018	AwardD (derivative)	180,360	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 8, 2017	AwardD (derivative)	70,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
SUTRO BIOPHARMA, INC.Listing on record	Jun 9, 2026	AwardD (derivative)	10,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Dec 29, 2025	AwardD (derivative)	1,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Jun 10, 2025	AwardD (derivative)	50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Aug 12, 2024	AwardD (derivative)	28,959	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SUTRO BIOPHARMA, INC.Listing on record	Aug 12, 2024	AwardD (derivative)	35,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,750	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-5,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-3,859	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-94,113	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-49,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-5,887	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-4,509	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-4,200	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,218	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jun 17, 2022	AwardD (derivative)	12,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 14, 2022	AwardD (derivative)	50,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Jan 28, 2022	AwardD (derivative)	12,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 17, 2021	AwardD (derivative)	30,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Aug 12, 2020	AwardD (derivative)	5,887	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Feb 27, 2020	AwardD (derivative)	94,113	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 5, 2019	AwardD (derivative)	200,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 7, 2018	AwardD (derivative)	180,360	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sierra Oncology, Inc.Listing unverified	Mar 8, 2017	AwardD (derivative)	70,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC